P.2.1.1. 10-point Cognitive Screener (10-CS) (≤5)

Download PDF (13M)

P.2.1.2. 10-point Cognitive Screener (10-CS) (≤7)

Download PDF (13M)

P.2.1.3. 10-point Cognitive Screener (10-CS) (≤8)

Download PDF (13M)

P.2.1.4. 6 item screener (≥0)

Download PDF (13M)

P.2.1.5. 6 item screener (≥1)

Download PDF (13M)

P.2.1.6. 6 item screener (≥2)

Download PDF (13M)

P.2.1.7. 6 item screener (≥3)

Download PDF (13M)

P.2.1.8. 6 item screener (≥4)

Download PDF (13M)

P.2.1.9. 6 item screener (≥5)

Download PDF (13M)

P.2.1.10. 6 item screener (≥6)

Download PDF (13M)

P.2.1.11. 6-item Cognitive Impairment Test (6CIT) (>9)

Download PDF (13M)

P.2.1.12. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.1.13. Addenbrooke’s Cognitive Examination, ACE (<75)

Download PDF (13M)

P.2.1.14. Addenbrooke’s Cognitive Examination, ACE (<83)

Download PDF (13M)

P.2.1.15. Addenbrooke’s Cognitive Examination, ACE (<88)

Download PDF (13M)

P.2.1.16. Addenbrooke’s Cognitive Examination-III, ACE- III (<81)

Download PDF (13M)

P.2.1.17. Addenbrooke’s Cognitive Examination-III, ACE- III (<82)

Download PDF (13M)

P.2.1.18. Addenbrooke’s Cognitive Examination-III, ACE- III (<84)

Download PDF (13M)

P.2.1.19. Addenbrooke’s Cognitive Examination-III, ACE- III (<88)

Download PDF (13M)

P.2.1.20. Addenbrooke’s Cognitive Examination-Revised, ACE-R (<74)

Download PDF (13M)

P.2.1.21. Addenbrooke’s Cognitive Examination-Revised, ACE-R (<83)

Download PDF (13M)

P.2.1.22. Addenbrooke’s Cognitive Examination-Revised, ACE-R (<85)

Download PDF (13M)

P.2.1.23. Addenbrooke’s Cognitive Examination-Revised, ACE-R (<89)

Download PDF (13M)

P.2.1.24. AD8 (≥2)

Download PDF (13M)

P.2.1.25. Abbreviated Mental Test, AMT (<10)

Download PDF (13M)

P.2.1.26. Abbreviated Mental Test, AMT (<7)

Download PDF (13M)

P.2.1.27. Abbreviated Mental Test, AMT (<8)

Download PDF (13M)

P.2.1.28. Abbreviated Mental Test, AMT (<9)

Download PDF (13M)

P.2.1.29. Amyloid Beta 1-42 and total tau

Download PDF (13M)

P.2.1.30. Applause sign (<3)

Download PDF (13M)

P.2.1.31. Boston Naming Test, BNT (<13)

Download PDF (13M)

P.2.1.32. Boston Naming Test, BNT (<14)

Download PDF (13M)

P.2.1.33. Boston Naming Test, BNT (<15)

Download PDF (13M)

P.2.1.34. Brief Neuropsychological Test Battery

Download PDF (13M)

P.2.1.35. Clock Drawing Test, CDT, Shulman scoring method (>0)

Download PDF (13M)

P.2.1.36. Clock Drawing Test, CDT, Shulman scoring method (>1)

Download PDF (13M)

P.2.1.37. Clock Drawing Test, CDT, Shulman scoring method (>2)

Download PDF (13M)

P.2.1.38. Clock Drawing Test, CDT, Shulman scoring method (>3)

Download PDF (13M)

P.2.1.39. Clock Drawing Test, CDT, Watson scoring method (>4)

Download PDF (13M)

P.2.1.40. Clock Drawing Test, CDT, Wolf-Klein scoring method (<7)

Download PDF (13M)

P.2.1.41. Clock Drawing Test, CDT, scoring method unclear (<8)

Download PDF (13M)

P.2.1.42. Clock Drawing Test, CDT, Manos and Wu scoring method (<8)

Download PDF (13M)

P.2.1.43. Clock Drawing Test, Clock Drawing Test, CDT, Manos and Wu scoring method (<9)

Download PDF (13M)

P.2.1.44. Clock Drawing Test, CDT, Lin scoring method (<3)

Download PDF (13M)

P.2.1.45. CERAD battery

Download PDF (13M)

P.2.1.46. Computed Tomography, CT

Download PDF (13M)

P.2.1.47. Functional Activities Questionnaire, FAQ (<9)

Download PDF (13M)

P.2.1.48. FDG-PET

Download PDF (13M)

P.2.1.49. Free recall score of 5- word test, ≤ 6 for all dementia

Download PDF (13M)

P.2.1.50. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.5)

Download PDF (13M)

P.2.1.51. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >4.1)

Download PDF (13M)

P.2.1.52. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >3.5)

Download PDF (13M)

P.2.1.53. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >3.6)

Download PDF (13M)

P.2.1.54. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >3.7)

Download PDF (13M)

P.2.1.55. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >3.8)

Download PDF (13M)

P.2.1.56. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >3.9)

Download PDF (13M)

P.2.1.57. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >4.0)

Download PDF (13M)

P.2.1.58. Informant Questionnaire on Cognitive Decline, IQCODE (26 item, >4.1)

Download PDF (13M)

P.2.1.59. Letter Sorting Test, LST (<1)

Download PDF (13M)

P.2.1.60. Letter Sorting Test, LST (<2)

Download PDF (13M)

P.2.1.61. Letter Sorting Test, LST (<3)

Download PDF (13M)

P.2.1.62. Mini-ACE (<26)

Download PDF (13M)

P.2.1.63. Mini-Cog (≤2)

Download PDF (13M)

P.2.1.64. Mini-Cog (Scanlan and Borson algorithm)

Download PDF (13M)

P.2.1.65. Memory Impairment Screen, MIS (<4)

Download PDF (13M)

P.2.1.66. Memory Impairment Screen, MIS (<5)

Download PDF (13M)

P.2.1.67. Memory Impairment Screen, MIS (<6)

Download PDF (13M)

P.2.1.68. Memory Impairment Screen, MIS (<7)

Download PDF (13M)

P.2.1.69. Memory Impairment Screen, MIS (<8)

Download PDF (13M)

P.2.1.70. MMSE (<17)

Download PDF (13M)

P.2.1.71. MMSE (<18)

Download PDF (13M)

P.2.1.72. MMSE (<19)

Download PDF (13M)

P.2.1.73. MMSE (<20)

Download PDF (13M)

P.2.1.74. MMSE (<21)

Download PDF (13M)

P.2.1.75. MMSE (<22)

Download PDF (13M)

P.2.1.76. MMSE (<23)

Download PDF (13M)

P.2.1.77. MMSE (<24)

Download PDF (13M)

P.2.1.78. MMSE (<25)

Download PDF (13M)

P.2.1.79. MMSE (<26)

Download PDF (13M)

P.2.1.80. MMSE (<27)

Download PDF (13M)

P.2.1.81. MMSE (<28)

Download PDF (13M)

P.2.1.82. Montreal Cognitive Assessment, MoCA (<19)

Download PDF (13M)

P.2.1.83. Montreal Cognitive Assessment, MoCA (<22)

Download PDF (13M)

P.2.1.84. Montreal Cognitive Assessment, MoCA (<24)

Download PDF (13M)

P.2.1.85. Montreal Cognitive Assessment, MoCA (<25)

Download PDF (13M)

P.2.1.86. Montreal Cognitive Assessment, MoCA (<26)

Download PDF (13M)

P.2.1.87. MRI

Download PDF (13M)

P.2.1.88. Orientation, OR (<7)

Download PDF (13M)

P.2.1.89. Orientation, OR (<8)

Download PDF (13M)

P.2.1.90. Palmo-Mental Reflex

Download PDF (13M)

P.2.1.91. Palmo-Mental Reflex and Short smell test, 1 positive

Download PDF (13M)

P.2.1.92. Palmo-Mental Reflex and Short smell test, both positive

Download PDF (13M)

P.2.1.93. Phototest (<27)

Download PDF (13M)

P.2.1.94. Rowland Universal Dementia Assessment Scale, RUDAS (<21)

Download PDF (13M)

P.2.1.95. Rowland Universal Dementia Assessment Scale, RUDAS (<22)

Download PDF (13M)

P.2.1.96. Rowland Universal Dementia Assessment Scale, RUDAS (<23)

Download PDF (13M)

P.2.1.97. Rowland Universal Dementia Assessment Scale, RUDAS (<24)

Download PDF (13M)

P.2.1.98. Rowland Universal Dementia Assessment Scale, RUDAS (<25)

Download PDF (13M)

P.2.1.99. Rowland Universal Dementia Assessment Scale, RUDAS (<26)

Download PDF (13M)

P.2.1.100. Seven Minute Screen (P>0.6)

Download PDF (13M)

P.2.1.101. Seven Minute Screen (P>0.7)

Download PDF (13M)

P.2.1.102. Seven Minute Screen (P>0.8)

Download PDF (13M)

P.2.1.103. Short smell test

Download PDF (13M)

P.2.1.104. Short Portable Mental Status Questionnaire, SPMSQ (≥4)

Download PDF (13M)

P.2.1.105. Short Portable Mental Status Questionnaire, SPMSQ (≥5)

Download PDF (13M)

P.2.1.106. Short Portable Mental Status Questionnaire, SPMSQ (≥6)

Download PDF (13M)

P.2.1.107. Syndrom Kurztest (≥7)

Download PDF (13M)

P.2.1.108. Syndrom Kurztest (≥8)

Download PDF (13M)

P.2.1.109. Syndrom Kurztest (≥9)

Download PDF (13M)

P.2.1.110. Total recall score of 5-word test, ≤ 9

Download PDF (13M)

P.2.1.111. Total weighted score of 5-word test, ≤ 15

Download PDF (13M)

P.2.1.112. Test Your Memory, TYM (≤30)

Download PDF (13M)

P.2.1.113. Test Your Memory, TYM (≤42)

Download PDF (13M)

P.2.1.114. Test Your Memory (≤39)

Download PDF (13M)

P.2.1.115. Verbal category fluency (animal naming), VF (<14)

Download PDF (13M)

P.2.1.116. Verbal category fluency (animal naming), VF (<19)

Download PDF (240K)

P.2.1.117. Verbal category fluency (animal naming), VF (<20)

Download PDF (13M)

P.2.1.118. Verbal category fluency (animal naming), VF (<21)

Download PDF (13M)

P.2.1.119. Verbal category fluency (animal naming), VF (<22)

Download PDF (13M)

P.2.1.120. Verbal category fluency (animal naming), VF (<23)

Download PDF (13M)

P.2.1.121. Verbal category fluency (animal naming), VF (<24)

Download PDF (13M)

P.2.2.1. Amyloid Beta 1-42

Download PDF (13M)

P.2.2.2. FDG-PET

Download PDF (13M)

P.2.2.3. MRI

Download PDF (13M)

P.2.3.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.3.2. Amyloid Beta 1-42 and Total Tau

Download PDF (13M)

P.2.3.3. FDG-PET

Download PDF (13M)

P.2.3.4. MRI

Download PDF (13M)

P.2.3.5. p-tau 181

Download PDF (13M)

P.2.4.1. Amyloid Beta 1-42

Download PDF (13M)

P.2.4.2. FDG-PET

Download PDF (13M)

P.2.5.1. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.2)

Download PDF (13M)

P.2.5.2. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.3)

Download PDF (13M)

P.2.5.3. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.4)

Download PDF (13M)

P.2.5.4. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.5)

Download PDF (13M)

P.2.5.5. Informant Questionnaire on Cognitive Decline, IQCODE (16 item, >3.6)

Download PDF (13M)

P.2.5.6. MMSE (<28)

Download PDF (13M)

P.2.5.7. p-tau 181

Download PDF (13M)

P.2.5.8. p-tau/Amyloid Beta 1-42

Download PDF (13M)

P.2.5.9. Total recall score of 5-word test, ≤ 9

Download PDF (13M)

P.2.5.10. Total Tau

Download PDF (13M)

P.2.5.11. Total weighted score of 5-word test, ≤ 15

Download PDF (13M)

P.2.6.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.6.2. MRI

Download PDF (13M)

P.2.7.1. ≥ 2 of 3 biomarkers abnormal (Amyloid Beta 1-42, t-tau, p-tau)

Download PDF (13M)

P.2.7.2. 2 out of 3 abnormal (Amyloid Beta 1–42, Total Tau, p-tau)

Download PDF (13M)

P.2.7.3. Amyloid Beta 1–42, Total Tau, p-tau abnormal

Download PDF (13M)

P.2.7.4. 99mTc-ECD SPECT, visual assessment method

Download PDF (13M)

P.2.7.5. 99mTc-ECD SPECT, all information method

Download PDF (13M)

P.2.7.6. 99mTc-ECD SPECT, automated method

Download PDF (13M)

P.2.7.7. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.7.8. Amyloid Beta 1-42

Download PDF (13M)

P.2.7.9. Amyloid Beta 1-42 and total tau

Download PDF (13M)

P.2.7.10. Amyloid Beta 1-42 and t-tau and/or p-tau abnormal

Download PDF (13M)

P.2.7.11. Amyloid Beta 1-42/p-tau 181

Download PDF (13M)

P.2.7.12. Amyloid Beta 1-42/Total Tau

Download PDF (13M)

P.2.7.13. Amyloid Beta 1-42/1- 40

Download PDF (13M)

P.2.7.14. EEG

Download PDF (13M)

P.2.7.15. FDG-PET

Download PDF (13M)

P.2.7.16. FDG-PET/CT

Download PDF (13M)

P.2.7.17. [18F] flutemetamol PET

Download PDF (13M)

P.2.7.18. Formula Hulstaert (biomarkers)

Download PDF (13M)

P.2.7.19. Formula Mattson (biomarkers)

Download PDF (13M)

P.2.7.20. Formula Mulder (biomarkers)

Download PDF (13M)

P.2.7.21. Formula Schoonenboom (biomarkers)

Download PDF (13M)

P.2.7.22. Mass Spectrometry

Download PDF (13M)

P.2.7.23. MRI

Download PDF (13M)

P.2.7.24. MRI Total Hippocampal grey matter volume, Hv. Cut off 4.95ml

Download PDF (13M)

P.2.7.25. MRI Hippocampal grey matter volume left, HVL. Cut- off 2.69 ml

Download PDF (13M)

P.2.7.26. MRI Hippocampal grey matter volume left/ total grey matter volume (HVL/GMV). Cut-off 4.69 per mille

Download PDF (13M)

P.2.7.27. MRI Hippocampal grey matter volume right, HVR. Cut off 2.70ml

Download PDF (13M)

P.2.7.28. MRI Hippocampal grey matter volume right/ total grey matter volume (HVR/GMV). Cut-off 4.54 per mille

Download PDF (13M)

P.2.7.29. MRI Total hippocampal grey matter volume/total grey matter volume (HV/GMV). Cut-off 8.36 per mille

Download PDF (13M)

P.2.7.30. Olfactory Test ≥ 3 errors

Download PDF (13M)

P.2.7.31. Olfactory Test ≥ 4 errors

Download PDF (13M)

P.2.7.32. Olfactory Test ≥ 5 errors

Download PDF (13M)

P.2.7.33. p-tau 181

Download PDF (13M)

P.2.7.34. p-tau and Amyloid Beta 1-42 combined then in case of discrepancy between p-tau and Amyloid Beta 1-42 the Amyloid Beta 42/40 ratio was used in place of Amyloid Beta 1-42

Download PDF (13M)

P.2.7.35. p-tau and Amyloid Beta 42/40

Download PDF (13M)

P.2.7.36. p-tau/Amyloid Beta 1-42

Download PDF (13M)

P.2.7.37. Total Tau

Download PDF (13M)

P.2.7.38. Total Tau/Amyloid Beta 1-42

Download PDF (13M)

P.2.7.39. Urinary AD7c-NTP (22ug/ml)

Download PDF (13M)

P.2.8.1. 99mTc-HMPAO SPECT

Download PDF (241K)

P.2.8.2. AD scale (≥6)

Download PDF (13M)

P.2.8.3. Amyloid Beta 1-42

Download PDF (13M)

P.2.8.4. Amyloid Beta 1-42 and total tau

Download PDF (13M)

P.2.8.5. Apo E (≥1 allele)

Download PDF (13M)

P.2.8.6. CSF 14-3-3, total Tau and p-tau

Download PDF (13M)

P.2.8.7. Computed Tomography, CT

Download PDF (13M)

P.2.8.8. FDG-PET

Download PDF (13M)

P.2.8.9. MRI

Download PDF (13M)

P.2.8.10. p-tau 181

Download PDF (227K)

P.2.8.11. p-tau/Amyloid Beta 1-42

Download PDF (13M)

P.2.8.12. Total tau

Download PDF (13M)

P.2.8.13. Total Tau/Amyloid Beta 1-42

Download PDF (13M)

P.2.9.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.9.2. Amyloid Beta 1-42

Download PDF (13M)

P.2.9.3. Computed Tomography, CT

Download PDF (13M)

P.2.9.4. MRI

Download PDF (13M)

P.2.10.1. FDG-PET

Download PDF (13M)

P.2.10.2. FDG-PET and MRI

Download PDF (13M)

P.2.10.3. FTDC criteria for bv FTD

Download PDF (13M)

P.2.10.4. FTDC criteria for possible bvFTD

Download PDF (13M)

P.2.10.5. FTDC criteria for probable bvFTD

Download PDF (13M)

P.2.10.6. MRI

Download PDF (13M)

P.2.11.1. FDG-PET

Download PDF (13M)

P.2.12.1. Skin biopsy

Download PDF (13M)

P.2.13.1. CBD consensus criteria

Download PDF (13M)

P.2.14.1. Amyloid Beta 1-42 and total tau

Download PDF (13M)

P.2.14.2. CSF 14-3-3 Automated Capillary Western Assay

Download PDF (13M)

P.2.14.3. CSF 14-3-3 (multiple methods)

Download PDF (13M)

P.2.14.4. CSF 14-3-3 ELISA

Download PDF (13M)

P.2.14.5. CSF 14-3-3 immunoblotting

Download PDF (13M)

P.2.14.6. CSF 14-3-3 (presence) and S100B (>1.0ng/ml)

Download PDF (13M)

P.2.14.7. CSF 14-3-3 and Amyloid Beta 1-42

Download PDF (13M)

P.2.14.8. CSF 14-3-3 and total Tau

Download PDF (13M)

P.2.14.9. CSF 14-3-3, total Tau and S100B

Download PDF (13M)

P.2.14.10. EEG

Download PDF (13M)

P.2.14.11. European criteria for CJD

Download PDF (13M)

P.2.14.12. French criteria for CJD

Download PDF (13M)

P.2.14.13. Master’s criteria for CJD

Download PDF (13M)

P.2.14.14. MRI

Download PDF (13M)

P.2.14.15. MRI, DWI

Download PDF (13M)

P.2.14.16. Neuron-specific enolase

Download PDF (13M)

P.2.14.17. New criteria for sporadic CJD

Download PDF (13M)

P.2.14.18. p-tau 181/total tau

Download PDF (13M)

P.2.14.19. RT-QuIC

Download PDF (13M)

P.2.14.20. S100B, 1.0ng/ml

Download PDF (13M)

P.2.14.21. S100B, 2.5ng/ml

Download PDF (13M)

P.2.14.22. S100B, 4.2ng/ml

Download PDF (13M)

P.2.14.23. Total Tau

Download PDF (13M)

P.2.14.24. Total Tau and S100B

Download PDF (13M)

P.2.14.25. WHO CJD criteria

Download PDF (13M)

P.2.15.1. Lewy body composite risk score, LBCRS, ≥ 3

Download PDF (13M)

P.2.15.2. MRI

Download PDF (13M)

P.2.16.1. MRI

Download PDF (13M)

P.2.17.1. 123I-FP-CIT SPECT

Download PDF (13M)

P.2.17.2. 123I-IMP SPECT

Download PDF (13M)

P.2.17.3. 123I-IMP SPECT and 123I-MIBG cardiac scintigraphy combined

Download PDF (13M)

P.2.17.4. 123I-MIBG cardiac scintigraphy

Download PDF (13M)

P.2.17.5. EEG

Download PDF (13M)

P.2.17.6. FDG-PET

Download PDF (13M)

P.2.17.7. MRI

Download PDF (13M)

P.2.17.8. RBD or two or more of visual hallucinations, Parkinsonism, and fluctuating attention and concentration

Download PDF (13M)

P.2.17.9. Two or more of fluctuating attention and concentration, visual hallucinations and Parkinsonism

Download PDF (13M)

P.2.17.10. Two or more of visual hallucinations, Parkinsonism or RBD

Download PDF (13M)

P.2.17.11. Two or more of visual hallucinations, Parkinsonism, fluctuating attention and concentration or RBD

Download PDF (13M)

P.2.18.1. 123I-FP-CIT SPECT

Download PDF (13M)

P.2.18.2. 123I-MIBG cardiac scintigraphy

Download PDF (13M)

P.2.18.3. DLB consensus criteria

Download PDF (13M)

P.2.18.4. FDG-PET

Download PDF (13M)

P.2.18.5. Lewy body composite risk score, LBCRS, ≥ 3

Download PDF (13M)

P.2.18.6. MRI

Download PDF (13M)

P.2.19.1. MRI

Download PDF (13M)

P.2.20.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.20.2. MRI

Download PDF (13M)

P.2.20.3. FTD versus DLB

P.2.20.4. FDG-PET

Download PDF (13M)

P.2.20.5. MRI

Download PDF (13M)

P.2.21.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.23.1. 99mTc-ECD SPECT, visual assessment

Download PDF (13M)

P.2.23.2. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.23.3. SPECT/PET

Download PDF (13M)

P.2.23.4. FDG-PET

Download PDF (13M)

P.2.23.5. FTD consensus criteria

Download PDF (13M)

P.2.23.6. MRI

Download PDF (13M)

P.2.24.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.24.2. FDG-PET

Download PDF (13M)

P.2.24.3. FTD scale (≥6)

Download PDF (244K)

P.2.24.4. MRI

Download PDF (13M)

P.2.25.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.25.2. MRI

Download PDF (13M)

P.2.26.1. HIV dementia scale (<10)

Download PDF (13M)

P.2.26.2. HIV dementia scale (<11)

Download PDF (13M)

P.2.26.3. International HIV Dementia scale (IHDS) (<10)

Download PDF (13M)

P.2.26.4. Grooved pegboard test

Download PDF (13M)

P.2.26.5. Modified HIV dementia scale (m-HDS) (<7.5)

Download PDF (13M)

P.2.26.6. Modified HIV dementia scale (m-HDS) and grooved pegboard combined

Download PDF (13M)

P.2.27.1. CSF EIA

Download PDF (13M)

P.2.27.2. FTA-ABS

Download PDF (13M)

P.2.27.3. INNO-LIA

Download PDF (13M)

P.2.27.4. PCR for T. pallidum genes: polA, Tpp47, and bmp

Download PDF (13M)

P.2.27.5. TPPA

Download PDF (13M)

P.2.28.1. 123I-MIBG cardiac scintigraphy

Download PDF (13M)

P.2.29.1. FCSRT-IR 3- FR (≤22)

Download PDF (13M)

P.2.29.2. Movement disorders criteria for PDD (≤120)

Download PDF (13M)

P.2.29.3. Movement disorders criteria for PDD (≤123)

Download PDF (13M)

P.2.29.4. Movement disorders criteria for PDD (≤132)

Download PDF (13M)

P.2.29.5. Rey-Osterrieth complex figure test, ROCF (≤22)

Download PDF (13M)

P.2.30.1. FDG-PET

Download PDF (13M)

P.2.31.1. Hachinski ischemic score, HIS (≥5)

Download PDF (13M)

P.2.32.1. ADDTC (possible)

Download PDF (13M)

P.2.32.2. ADDTC (probable)

Download PDF (13M)

P.2.32.3. ADDTC criteria

Download PDF (13M)

P.2.32.4. Hachinski ischemic score, HIS (≥7)

Download PDF (13M)

P.2.32.5. NINDS-AIREN (possible)

Download PDF (13M)

P.2.32.6. NINDS-AIREN (probable)

Download PDF (13M)

P.2.32.7. NINDS-AIREN criteria

Download PDF (13M)

P.2.33.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.33.2. MRI

Download PDF (13M)

P.2.34.1. MRI

Download PDF (13M)

P.2.35.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.35.2. MRI

Download PDF (13M)

P.2.36.1. MRI

Download PDF (13M)

P.2.37.1. 99mTc-HMPAO SPECT

Download PDF (13M)

P.2.39.1. HIS (≥7)

Download PDF (13M)

P.2.39.2. MRI

Download PDF (13M)